Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MOLNUPIRAVIR Cause Incorrect dose administered? 95 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Incorrect dose administered have been filed in association with MOLNUPIRAVIR (LAGEVRIO). This represents 2.0% of all adverse event reports for MOLNUPIRAVIR.

95
Reports of Incorrect dose administered with MOLNUPIRAVIR
2.0%
of all MOLNUPIRAVIR reports
0
Deaths
3
Hospitalizations

How Dangerous Is Incorrect dose administered From MOLNUPIRAVIR?

Of the 95 reports, 3 (3.2%) required hospitalization, and 2 (2.1%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MOLNUPIRAVIR. However, 95 reports have been filed with the FAERS database.

What Other Side Effects Does MOLNUPIRAVIR Cause?

Product use issue (706) No adverse event (614) Covid-19 (396) Wrong technique in product usage process (380) Product use in unapproved indication (296) Diarrhoea (259) Accidental underdose (207) Product use complaint (206) Rash (200) Underdose (183)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which MOLNUPIRAVIR Alternatives Have Lower Incorrect dose administered Risk?

MOLNUPIRAVIR vs MOLSIDOMINE MOLNUPIRAVIR vs MOMELOTINIB MOLNUPIRAVIR vs MOMETASONE MOLNUPIRAVIR vs MOMETASONE FUROATE MOLNUPIRAVIR vs MOMETASONE FUROATE\OLOPATADINE

Related Pages

MOLNUPIRAVIR Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered MOLNUPIRAVIR Demographics